Managing genital herpes infections in pregnancy

Women's Health

Volumn 5, Issue 2, 2009, Pages 165-174

  Aga, Irene E ^a   Hollier, Lisa M ^a  

^a LBJ General Hospital   (United States)

Author keywords

Genital herpes; Herpes simplex virus; Management; Neonatal herpes; Pregnancy

Indexed keywords

ACICLOVIR; VALACICLOVIR; ANTIVIRUS AGENT;

ANTIBODY DETECTION; CESAREAN SECTION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG SAFETY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENITAL HERPES; GESTATIONAL AGE; HUMAN; INFECTION RISK; NEWBORN INFECTION; POLYMERASE CHAIN REACTION; PREGNANCY; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; RECURRENT INFECTION; REVIEW; RISK FACTOR; SCREENING TEST; SEROLOGY; SEROPREVALENCE; SEX DIFFERENCE; TREATMENT DURATION; TREATMENT INDICATION; VIRUS DETECTION; VIRUS ENTRY; VIRUS REACTIVATION; VIRUS SHEDDING; VIRUS TRANSMISSION; DISEASE TRANSMISSION; MEDICAL EDUCATION; NEWBORN; PREGNANCY COMPLICATION; VIROLOGY;

ANTIVIRAL AGENTS; CESAREAN SECTION; EDUCATION, MEDICAL, CONTINUING; FEMALE; HERPES GENITALIS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 67650170916     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.5.2.165     Document Type: Review

References (58)

1. Dolan A, Jamieson FE, Cunningham C, Barnett BC, McGeoch DJ: The genome sequence of herpes simplex virus type 2. J. Virol. 72, 2010-2021 (1998).
2. Langenberg AGM, Corey L, Ashley RL, Leong WP, Straus SE: A prospective study of new infections with herpes simplex virus type 1 and type 2. N. Engl. J. Med. 341, 1432-1438 (1999).
3. Gupta R, Warren T, Wald A: Genital herpes. Lancet 370(9605), 2127-2137 (2007).
4. Xu F, Sternberg MR, Kottiri BJ et al.: Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296(8), 964-973 (2006).
5. Wutzler P, Doerr HW, Farber I et al.: Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations: relevance for the incidence of genital herpes. J. Med. Virol. 61(2), 201-207 (2000).
6. Cunningham AL, Taylor R, Taylor J, Marks C, Shaw J, Mindel A: Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sex Trans. Infect. 82(2), 164-168 (2006).
7. Cowan FM, French RS, Mayaud P et al.: Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex Trans. Infect. 79(4), 286-290 (2004).
8. Nahmias A, Lee F, Beckman-Nahmias S: Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand. J. Infect. Dis. 69, 19-36 (1990).
9. Mertz GJ, Rosenthal SL, Stanberry LR: Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes? Sex Trans. Dis. 30, 801-802 (2003).
10. Roberts CM, Pfister JR, Spear SJ: Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Trans. Dis. 30, 797-800 (2003).
11. Scoular A, Norrie J, Gillespie G, Mir N, Carman WF: Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. Br. Med. J. 324, 1366-1367 (2002).
12. Wald A, Zeh J, Selke S et al.: Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N. Engl. J. Med. 342(12), 844-850 (2000).
13. Mertz GL, Benedetti J, Ashley R, Selke SA, Corey L: Risk factors for the sexual transmission of genital herpes. Ann. Intern. Med. 116, 197-202 (1992).
14. Wald A: Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes 11(Suppl. 3), 130A-137A (2004).
15. Brown ZA, Selke S, Zeh J et al.: The acquisition of herpes simplex virus during pregnancy. N. Engl. J. Med. 337, 509-515 (1997).
16. Gardella C, Brown Z, Wald A et al.: Risk factors for herpes simplex virus transmission to pregnant women: a couples study. Am. J. Obstet. Gynecol. 193, 1891-1899 (2005).
17. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE: A prospective study of new infections with herpes simplex virus type 1 and type 2. N. Engl. J. Med. 341, 1432-1438 (1999).
18. Sheffield JS, Hill JB, Hollier LM et al.: Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Obstet. Gynecol. 108, 141-147 (2006).
19. Watts DH, Brown ZA, Money D et al.: A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am. J. Obstet. Gynecol. 188, 836-843 (2003).
20. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L: Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289, 203-209 (2003).
21. ACOG Committee on Practice Bulletins: ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82, June 2007. Management of herpes in pregnancy. Obstet. Gynecol. 109(6), 1489-1498 (2007).
22. Brown ZA, Benedetti J, Ashley R et al.: Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N. Engl. J. Med. 324, 1247 (1991).
23. Hutto C, Arvin A, Jacobs R et al.: Intrauterine herpes simplex virus infections. J. Pediatr. 110, 97-101 (1987).
24. Whitley RJ, Corey L, Arvin A et al.: Changing presentation of herpes simplex virus infection in neonates. J. Infect. Dis. 158, 109-116 (1988).
25. Dinh RH, Dunne EF, Markowitz LE, Weinstock H, Berman S: Assessing neonatal herpes reporting in the United States, 2000-2005. Sex Trans. Dis. 35(1), 19-21 (2008).
26. Mahnert N, Roberts SW, Laibl VR, Sheffield JS, Wendel GD: The incidence of neonatal herpes infection. Am. J. Obstet. Gynecol. 196(5), E55-E556 (2007).
27. Poeran J, Wildschut H, Gaytant M, Galama J, Steegers E, van der Meijden W: The incidence of neonatal herpes in The Netherlands. J. Clin. Virol. 42(4), 321-325 (2008).
28. Whitley R, Arvin A, Prober C et al.: A controlled trial comparing vidarabine with acyclovir in neonates with herpes simplex virus infection. N. Engl. J. Med. 324, 444-449 (1991).
29. Kimberlin DW, Lin CY, Jacobs RF et al.: Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 108, 230-238 (2001).
30. Centers for Disease Control and Prevention, Workowski KA, Berman SM: Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm. Rep. 55(RR-11), 16-20 (2006).
31. Slomka MJ, Emery L, Munday PE, Moulsdale M, Brown DW: A comparison of PCR with virus isolation and direct antigen detection for diagnosis of typing of genital herpes. J. Med. Virol. 55, 177-183 (1998).
32. Wald A, Huang ML, Carrell D, Selke S, Corey L: Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J. Infect. Dis. 188, 1345-1351 (2003).
33. Moseley RC, Corey L, Benjamin D, Winter C, Remington ML: Comparison of viral isolation, direct immunofluorescence, and indirect immunoperoxidase techniques for detection of genital herpes simplex virus infection. J. Clin. Microbiol. 13, 913-918 (1981).
34. Cone RW, Hobson AC, Palmer J, Remington M, Corey L: Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reaction. J. Infect. Dis. 164, 757-760 (1991).
35. Cone R, Hobson A, Brown Z et al.: Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA 272, 792-796 (1994).
36. Morrow RA, Friedrich D, Meier A, Corey L: Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA. BMC Infect. Dis. 5, 84-90 (2005).
37. Turner KR, Wong EH, Kent CK, Klausner JD: Serologic herpes testing the in the real world. Validation of new type-specific serologic herpes simplex virus tests in a public health laboratory. Sex Trans. Dis. 29, 422-425 (2002).
38. Wald A, Ericsson M, Krantz E, Selke S, Corey L: Oral shedding of herpes simplex virus type 2. Sex Trans. Infect. 80, 272-276 (2004).
39. Cleary KL, Pare E, Stamilio D, Macones GA: Type-specific screening for asymptomatic herpes infection in pregnancy: a decision analysis. BJOG 112(6), 731-736 (2005).
40. Thung SF, Grobman WA: The cost-effectiveness of routine antenatal screening for maternal herpes simplex virus-1 and -2 antibodies. Am. J. Obstet. Gynecol. 192(2), 483-488 (2005).
41. Baker D, Brown Z, Hollier LM et al.: Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Am. J. Obstet. Gynecol. 191(6), 2074-2084 (2004).
42. Barnabas RV, Carabin H, Garnett GP: The potential role of suppressive therapy for sex partners in the prevention of neonatal herpes: a health economic analysis. Sex Trans. Infect. 78(6), 425-429 (2002).
43. Rouse DJ, Stringer JS: An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes. Am. J. Obstet. Gynecol. 183(2), 400-406 (2000).
44. Corey L, Wald A, Patel R et al.: Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N. Engl. J. Med. 350, 11-20 (2004).
45. Ratanajamit C, Vinther Skriver M, Jepsen P, Chongsuvivatwong V, Olsen J, Sorensen HT: Adverse pregnancy outcomes in women exposed to acyclovir during pregnancy: a population-based observational study. Scand. J. Infect. Dis. 35, 255-259 (2003).
46. Bryson YJ, Dillon M, Lovett M et al.: Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N. Engl. J. Med. 308, 916-921 (1983).
47. Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD: Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet. Gynecol. 102, 1396-1403 (2003).
48. Hollier LM, Wendel GD: Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database Syst. Rev. (1), CD004946 (2008).
49. Arvin AM, Whitley RJ: Herpes simplex virus infections. In: Infectious Diseases of the Fetus and Newborn Infant (5th Edition). Remington JS, Klein JO (Eds). WB Saunders, Philadelphia, PA, USA (2001).
50. Ashley RL, Dalessio J, Burchett S et al.: Herpes simplex virus-2 (HSV-2) type-specific antibody correlates of protection in infants exposed to HSV-2 at birth. J. Clin. Invest. 90(2), 511-514 (1992).
51. Society of Obstetricians and Gynaecologists of Canada: Guidelines for the management of herpes simplex virus in pregnancy. J. Obstet. Gynaecol. Can. 30(6), 514-519 (2008).
52. Peng J, Krause PJ, Kresch M: Neonatal herpes simplex virus infection after cesarean section with intact amniotic membranes. J. Perinatol. 16, 397-399 (1996).
53. Nahmias AJ, Josey WE, Naib ZM, Freeman MG, Fernandez RJ, Wheeler JH: Perinatal risk associated with maternal genital herpes simplex virus infection. Am. J. Obstet. Gynecol. 110, 825-837 (1971).
54. Douglas J, Schmidt O, Corey L: Acquisition of neonatal HSV-1 infection from a paternal source contact. J. Pediatr. 103, 908-910 (1983).
55. Hammerberg O, Watts J, Chernesky M, Luchsinger I, Rawls W: An outbreak of herpes simplex virus type 1 in an intensive care nursery. Pediatr. Infect. Dis. J. 2, 290-294 (1983).
56. Sheffield JS, Fish DN, Hollier LM, Cadematori S, Nobles BJ, Wendel GD: Acyclovir concentrations in human breast milk after valacyclovir administration. Am. J. Obstet. Gynecol. 186, 100-102 (2002).
57. Handsfield HH, Waldo AB, Brown ZA et al.: Neonatal herpes should be a reportable disease. Sex Trans. Dis. 32(9), 521-525 (2005).
58. Stanberry LR, Spruance SL, Cunningham AL et al.: Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N. Engl. J. Med. 347, 1652-1661 (2002).